20/20 HealthCare Partners
  • Home
  • What Differentiates 20/20 HCP
  • Team
  • Companies
    • Companies
    • Exits
  • News
  • Contact

20/20 HealthCare Partners

22 Oct2015

VBL Therapeutics Presents Positive Data on VB-111 in Advanced Radioactive Iodine Refractory Differentiated Thyroid Cancer at the ITC 2015 Conference

Written by 2020HCP.com. Posted in News

Multi-Cohort Phase 2 Trial Met Its Primary Endpoint of 6-Month PFS
TEL AVIV, Israel, Oct. 21, 2015 (GLOBE NEWSWIRE) — VBL Therapeutics (NASDAQ:VBLT), today announced positive results from its multi-cohort Phase 2 trial of VB-111 in advanced radioiodine-refractory differentiated thyroid cancer (RAIR-DTC). The pre-specified primary trial endpoint of 6-month Progression Free Survival (PFS) for at least 25% of enrolled patients was met, showing a dose response for VB-111. In the trial, which was conducted at the Mayo Clinic and Massachusetts General Hospital, VB-111 also demonstrated favorable safety and survival data, and a potential for dose-dependent disease stabilization. The results were presented today at the 15th International Thyroid Congress held in Orlando, FL.
  • Continue Reading
12 Oct2015

Corindus Vascular Robotics and Mayo Clinic Launch Vascular Robotic Program to Research Physician Safety

Written by 2020HCP.com. Posted in News

WALTHAM, MA – October 12, 2015 – Corindus Vascular Robotics [NYSE MKT: CVRS] today announced the formation of a joint robotic-assisted percutaneous coronary intervention (PCI) research and clinical program. The program utilizes the company’s CorPath® System, the first and only FDA-cleared medical device to provide robotic-assisted precision to coronary PCI procedures while protecting hospital employees from occupational radiation exposure and orthopedic stress and strain.
  • Continue Reading
01 Oct2015

Konica Minolta Acquires Viztek to Enhance Healthcare IT Solution Capabilities

Written by 2020HCP.com. Posted in News, Uncategorized

Wayne, NJ, October 1, 2015 – Konica Minolta, Inc. today announced the completed acquisition of Garner, North Carolina based Viztek, LLC, a leading innovative healthcare company, through Konica Minolta Medical Imaging. With this acquisition, Konica Minolta enhances its capabilities to offer comprehensive, end-to-end healthcare IT solutions from image acquisition to physician diagnosis. It also adds to the established strength
  • Continue Reading
01 Jun2015

UltraSPECT to Present Xpress Suite of Safer Imaging Solutions at SNMMI 2015

Written by 2020HCP.com. Posted in News

 SNMMI Attendees Invited to Take Part in New “Hot Trot 5K” Run/Walk to Benefit Professional Development of Nuclear Medicine Technologists Auburndale, Mass., June 1, 2015 (SNMMI Booth #517) – UltraSPECT, a provider of the most cost-effective and vendor-neutral low dose and ultra-low-dose nuclear medicine imaging solutions, will present its Xpress suite of value packages at booth #517 during the Society of Nuclear Medicine & Molecular Imaging (SNMMI) annual meeting from June 6-10 in Baltimore, MD. Low dose imaging increases safety for patients and technologists while providing physicians with high-quality images for accurate diagnosis.
  • Continue Reading
28 May2014

20/20 HealthCare Partners Collaborates with Roche to Source and Advance BioTech Innovations

Written by 2020HCP.com. Posted in News

May 28, 2014 – Auburndale, Mass. – 20/20 HealthCare Partners LLC (20/20 HCP), a global investment group focused on early stage medical technology and life science innovation, is pleased to announce an agreement with Roche, in which they will source and identify novel treatments and/or technologies in the biotech arena. These areas include oncology/immuno-oncology, neurology, infectious diseases, inflammation and ophthalmology. The partnership aims to advance any identified technologies by facilitating collaborations or the formation of new life science companies.
  • Continue Reading
  • 1
  • ...
  • 10
  • 11
  • 12
  • 13

Latest News

  • XRHealth and Amelia Virtual Care Announce Merger, Creating the Largest XR Therapeutics Platform in the World April 18, 2023
  • Variantyx Secures $20M Debt Financing to Support Precision Medicine in North America, Europe October 18, 2022
  • SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting June 21, 2022
  • SQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the Treatment of HPV16+ Tumors April 28, 2022
  • SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo April 11, 2022

20/20 HealthCare Partners | 2000 Commonwealth Ave, Suite 200, Auburndale, MA 02466 | Contact Us

Copyright © 2019
  • Home
  • What Differentiates 20/20 HCP
  • Team
  • Companies
    • Companies
    • Exits
  • News
  • Contact